Rat Blood Cell Sample |
Reduced Glutathione (GSH)* |
Glutathione Reductase (GR)*b |
Glutathione Peroxidase (GPx)*b |
||||||||||
|
mg/100mL RBC |
mg/g Hb |
IU/g of Hb |
IU/g of Hb |
|||||||||
Control |
24.42 ±1.18 |
1.58 ±0.121 |
7.34 ±0.34 |
25.23 ±1.02 |
|||||||||
Indomethacin |
20.44 ±0.90a |
1.426 ±0.007a |
7.38 ±0.39 |
25.90 ±0.91 |
|||||||||
Indomethacin + Vitamin E |
23.54 ±0.30a |
1.487 ±0.045 |
7.85 ±0.40 |
24.95 ±1.21 |
|||||||||
* Each value is the mean of at least 3-4 experiments ±SD |
Rat Blood Cell Sample |
Acetylcholinesterase (AChE) Activity*b |
(Na+,K+)-ATPase Activity*c |
|||||||||||
|
IU/g of Hb |
µmole Pi/mg Protein |
|||||||||||
Control |
16.55 ±1.27 |
0.162 ±0.010 |
|||||||||||
Indomethacin |
29.42 ±0.96a |
0.168 ±0.008 |
|||||||||||
Indomethacin + Vitamin E |
27.06 ±1.71 |
0.166 ±0.006 |
|||||||||||
* Each value is the mean of at least 3-4 experiments ±1SD |
|
% Hemolysis |
||||||||||||
% NaCl |
Control (No Drug Treatment) |
Indomethacin |
Indomethacin + Vitamin E |
||||||||||
0.1 |
98.91 ±0.78 |
98.29 ±1.38 |
98.74 ±0.70 |
||||||||||
0.2 |
97.23 ±2.23 |
94.16 ±1.59 |
94.53 ±0.52 |
||||||||||
0.3 |
100 ±0.00 |
100 ±0.00 |
100 ±0.00 |
||||||||||
0.4 |
97.64 ±2.05 |
97.83 ±0.96 |
96.89 ±0.80 |
||||||||||
0.5 |
96.27 ±1.16 |
96.18 ±2.04 |
94.98 ±1.77 |
||||||||||
0.6 |
92.2 ±1.64 |
92.69±2.84 |
92.84 ±2.68 |
||||||||||
0.65 |
92.27 ±3.54 |
85.86 ±3.17 |
86.96 ±3.59 |
||||||||||
0.7 |
76.39 ±3.94 |
59.49 ±2.59 |
66.07 ±15.19 |
||||||||||
0.75 |
43.80 ±7.87 |
24.05 ±3.88 |
36.29 ±9.00 |
||||||||||
0.8 |
14.22 ±4.98 |
6.78±0.77 |
8.65 ±1.36 |
||||||||||
0.85 |
4.34 ±0.97 |
1.43 ±0.96 |
2.79 ±0.47 |
||||||||||
0.9 |
0.00 ±0.00 |
0.00 ±0.00 |
0.0 0.00 |
||||||||||
Severe acute malnutrition (<11.5cm) |
78 |
68.5 |
|||||||||||
Erythrocyte osmotic fragility was assessed as a % Hemolysis of control, Indomethacin-treated and Indomethacin + vitamin E-treated |